Despite an increased periostin level described in children with asthma [94,95], periostin is unlikely to be a useful biomarker of type 2 inflammation in children, mainly because its levels increase due to bone growth and this may overlap with local production within the airways [93,96]. Here, POSTN is linked to asthma.